Johnson & Johnson JNJ, +1.05% stock rose nearly 3% in the extended session Tuesday after the company said it was setting aside $8.9 billion to settle claims connected with cosmetic-talc litigation.
9 billion, payable over 25 years, to resolve “all the current and future talc claims.” That’s an increase of $6.9 billion over the $2 billion previously committed in connection with LTL’s initial bankruptcy filing in October 2021, the company said.